Tag: ferroportin
-
Takeda Wins FDA Approval for First-in-Class Mimrylo in Polycythemia Vera
The FDA approved Mimrylo (rusfertide), the first hepcidin mimetic for polycythemia vera, introducing iron restriction as a new strategy to control excessive red blood cell production.
-
How Rusfertide Controls Red Blood Cell Overproduction in Polycythemia Vera
Rusfertide mimics hepcidin to reduce ferroportin-mediated iron export, restricting the iron available for excessive red blood cell production in polycythemia vera.